Download the list of NSQ samples for July 2022, link is given below: The Central Drugs Standard Control Organisation (CDSCO) has declared 53 drug samples out of a total of 1337 drug samples tested as not of standard quality (NSQ) and one declared as misbranded and none spurious during the month of July 2022.

Click here to download NSQ list July 2022

Out of the 1337 samples tested during the month, 1283 samples came out with standard quality, while 53 samples were declared as not of standard quality (NSQ) & one declared as misbranded and none as spurious.

Picture: Pixabay

None of the samples were identified as spurious and one declared S adulterated during the month. Every month, the drug regulator comes up with a list of drugs, medical devices, and cosmetics that are declared not of standard quality / spurious / adulterated / misbranded, every month.

Click to download month and year wise lists of NSQ drugs

During the month of June, 2022, the authorities tested 1096 samples, out of which 1070 samples were tested as of standard quality. The number of samples declared as not of standard quality was 26 and none as misbranded and spurious.

During the month of May, 2022, the authorities tested 1233 samples, out of which 1192 samples were tested as of standard quality. The number of samples declared as not of standard quality was 41 and none as misbranded and spurious.

During the month of April, 2022, the authorities tested 1164 samples, out of which 1137 samples were tested as of standard quality. The number of samples declared as not of standard quality was 27 and none as misbranded and spurious.

During the month of March, 2022, the authorities tested 1454 samples, out of which 1406 samples were tested as of standard quality. The number of samples declared as not of standard quality was 48 and none as misbranded.

During the month of February, 2022, the authorities tested 1221 samples, out of which 1181 samples were tested as of standard quality. The number of samples declared as not of standard quality was 39 and one as misbranded.

During the month of January, 2022, the authorities tested 1227 samples, out of which 1200 samples were tested as of standard quality. The number of samples declared as not of standard quality was 27 and none as misbranded.

The test samples were drawn by the zonal and sub-zonal offices of CDSCO, and tested in the drug testing laboratories i.e CDL, CDTLs & RDTLs in Kolkata, Mumbai, Hyderabad, Chandigarh, and Guwahati.

Month wise drug alerts, click to download below links

Drug alert: 26 out of 1096 samples declared as NSQ in June 2022

Drug alert: 41 out of 1233 samples declared as NSQ in May 2022

Drug alert: 27 out of 1164 samples declared as NSQ in April 2022

Drug alert: 48 out of 1454 samples declared as NSQ in March 2022

Drug alert: 40 out of 1221 samples declared as NSQ in February 2022

Drug alert: 27 out of 1227 samples declared as NSQ in January 2022

Drug alert: 33 out of 1385 samples declared as NSQ in December 2021

Drug alert: 22 out of 1102 samples declared as NSQ in November 2021

Drug alert: 36 out of 1061 samples declared as NSQ in October 2021

Drug alert: 42 out of 1227 samples declared as NSQ in September 2021

Medical Device Alert: Lists

Commercial Testing Laboratories

Govt Laboratories

List of Laboratory instruments

Latest Notifications: Testing Laboratories

CDSCO Panel gives nod for clinical trial of Elagolix 150 mg for Endometriosis

This drug can fight more than 300 drug-resistant bacteria

20 Blood Banks fined ₹2.3cr for overcharging

Drug recall: Glenmark, Sun, Dr Reddy’s recalled these Drugs

3 strategies to combat Counterfeit drugs and Pharma supply chain threats

USFDA gives approval for Meclizine HCL Tablets

Johnson & Johnson to end global sales of talc-based baby powder

USFDA gives nod for Prochlorperazine Maleate Tablets

Possible carcinogen found in some Diabetes drugs: USFDA

Latest Notifications regarding Pharmaceuticals
https://thehealthmaster.com/2022/08/16/drug-alert-53-out-of-1337-samples-declared-as-nsq-in-july-2022/